President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...
Stocks to Buy or Sell. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other ...
Obesity drugs - especially Novo Nordic's Ozempic - dominated healthcare headlines in 2024, but Matt Miskin of John Hancock ...
Shares are mixed in Asia after U.S. stocks edged back from their all-time high, with many regional markets closed for lunar ...
US stocks closed lower afer the S&P 500 touched an intraday record high early in the day. As tariff worries eased, mixed ...
The three laggards were energy stocks, off 1.1%, industrials, sliding 0.5%, and consumer staples, falling 0.4%. The S&P 500 reached new records on Friday as optimism around the start of President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback